Management issues of neuropathic trigeminal pain from a medical perspective.
The purpose of this article is to review the pharmacological treatment of neuropathic trigeminal pain by means of a systematic review. A number of randomized controlled trials and important historical and uncontrolled studies in trigeminal neuralgia and postherpetic neuralgia were identified. Trigeminal neuralgia is a unique neuropathic pain disorder with a specific therapy. It does not respond to the usual drugs used for other neuropathic pains. The drug therapy of trigeminal postherpetic neuralgia is similar to that of other neuropathic trigeminal pain conditions.
Watson
C Peter N
CP
Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
D000588:Amines / Q000627:therapeutic use; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000627:therapeutic use; D001418:Baclofen / Q000627:therapeutic use; D002220:Carbamazepine / Q000627:therapeutic use; D020209:Cranial Nerve Injuries / Q000150:complications*; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use; D005156:Facial Neuralgia / Q000188:drug therapy / Q000209:etiology; D005157:Facial Pain / Q000188:drug therapy* / Q000209:etiology; D000077206:Gabapentin; D006562:Herpes Zoster / Q000150:complications; D006801:Humans; D000077213:Lamotrigine; D009294:Narcotics / Q000627:therapeutic use; D010672:Phenytoin / Q000627:therapeutic use; D014227:Triazines / Q000627:therapeutic use; D061221:Trigeminal Nerve Injuries; D014277:Trigeminal Neuralgia / Q000188:drug therapy* / Q000209:etiology; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use
D000588:Amines; D018712:Analgesics, Non-Narcotic; D000927:Anticonvulsants; D000928:Antidepressive Agents; D003509:Cyclohexanecarboxylic Acids; D009294:Narcotics; D014227:Triazines; D002220:Carbamazepine; D005680:gamma-Aminobutyric Acid; D010672:Phenytoin; D000077206:Gabapentin; D001418:Baclofen; D000077213:Lamotrigine